The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula I: ##STR1##

or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(NH)NH₂, which are useful as inhibitors of factor Xa.